These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 7922386

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cellular mechanisms in sepsis.
    Jean-Baptiste E.
    J Intensive Care Med; 2007; 22(2):63-72. PubMed ID: 17456726
    [Abstract] [Full Text] [Related]

  • 5. Cytokine and anti-cytokine strategies in inflammatory reaction modulation.
    Delannoy I, Lekeux P, Miossec P.
    Vet Res; 1993; 24(6):449-67. PubMed ID: 8111428
    [Abstract] [Full Text] [Related]

  • 6. Current prospects for the treatment of clinical sepsis.
    Suffredini AF.
    Crit Care Med; 1994 Jul; 22(7):S12-8. PubMed ID: 8026188
    [Abstract] [Full Text] [Related]

  • 7. Immune dysfunction in murine polymicrobial sepsis: mediators, macrophages, lymphocytes and apoptosis.
    Ayala A, Chaudry IH.
    Shock; 1996 Jul; 6 Suppl 1():S27-38. PubMed ID: 8828095
    [Abstract] [Full Text] [Related]

  • 8. Calcium: a regulator of the inflammatory response in endotoxemia and sepsis.
    Hotchkiss RS, Karl IE.
    New Horiz; 1996 Feb; 4(1):58-71. PubMed ID: 8689276
    [Abstract] [Full Text] [Related]

  • 9. [Humoral mediators in the pathophysiology of organ dysfunction in sepsis].
    Oda S, Hirasawa H, Shiga H, Matsuda K, Ueno H, Nakamura M, Watanabe E.
    Nihon Geka Gakkai Zasshi; 2003 Jul; 104(7):511-7. PubMed ID: 12884775
    [Abstract] [Full Text] [Related]

  • 10. The importance of systemic cytokines in the pathogenesis of polymicrobial sepsis and dehydroepiandrosterone treatment in a rodent model.
    Hildebrand F, Pape HC, Hoevel P, Krettek C, van Griensven M.
    Shock; 2003 Oct; 20(4):338-46. PubMed ID: 14501948
    [Abstract] [Full Text] [Related]

  • 11. Endotoxin, tumor necrosis factor, and related mediators: new approaches to shock.
    Beutler B.
    New Horiz; 1993 Feb; 1(1):3-12. PubMed ID: 7922391
    [Abstract] [Full Text] [Related]

  • 12. An update on the pathophysiology of sepsis.
    le Roux P.
    SADJ; 2004 May; 59(4):163, 165. PubMed ID: 15279093
    [Abstract] [Full Text] [Related]

  • 13. Mediators of septic shock: new approaches for interrupting the endogenous inflammatory cascade.
    Giroir BP.
    Crit Care Med; 1993 May; 21(5):780-9. PubMed ID: 8482101
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interleukin-10 prevents early cytokine release in severe intraabdominal infection and sepsis.
    Rongione AJ, Kusske AM, Ashley SW, Reber HA, McFadden DW.
    J Surg Res; 1997 Jul 01; 70(2):107-12. PubMed ID: 9237883
    [Abstract] [Full Text] [Related]

  • 18. Sepsis in critical care.
    King JE.
    Crit Care Nurs Clin North Am; 2007 Mar 01; 19(1):77-86. PubMed ID: 17338953
    [Abstract] [Full Text] [Related]

  • 19. Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations.
    Balk RA.
    Dis Mon; 2004 Apr 01; 50(4):168-213. PubMed ID: 15133467
    [Abstract] [Full Text] [Related]

  • 20. Immune modulation and sepsis.
    Karzai W, Reinhart K.
    Int J Clin Pract; 1997 Jun 01; 51(4):232-7. PubMed ID: 9287265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.